Corporate digest

QT Vascular

QT Vascular and its chief executive officer Eitan Konstantino have successfully defended themselves against a patent infringement lawsuit filed by another medical firm, AngioScore, the Catalist-listed group said in a bourse filing on Wednesday. This means that it can continue to sell its "Chocolate PTA" balloon catheter without impediment, it added.

AngioScore, a specialty balloon angioplasty firm that was co-founded by Dr Konstantino, had claimed that Chocolate PTA infringed the "119 Patent" - a patent that claims a very specific design for an angioplasty balloon catheter and a non-deployable stent. However, QT Vascular said on Wednesday the jury's unanimous verdict "confirms that Chocolate is substantially different from the design disclosed in the '119 patent'".